Fauna Bio: Funding, Investors & Team (Sep 2026)
Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bio leverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.
Fauna Bio has raised $9.0M across 1 funding round on record, the most recent a Seed of $9.0M announced in Sep 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Fauna Bio Company Profile and Key Stats
Latest funding round on record: Sep 2021.
Fauna Bio Funding Rounds
Fauna Bio Founders and Leadership Team
Contact details for the Fauna Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Fauna Bio Funding Compared to Other Biotechnology Startups
Fauna Bio's latest round of $9.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Fauna Bio in Biotechnology and Berkeley
Companies Similar to Fauna Bio
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Fauna Bio Funding FAQs
What does Fauna Bio do?
Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bio leverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.
How much funding has Fauna Bio raised?
Fauna Bio has raised $9.0M across 1 round on record. The most recent is a Seed of $9.0M announced in Sep 2021.
When did Fauna Bio last raise funding?
Fauna Bio's most recent funding round on record is a Seed of $9.0M, announced in Sep 2021.
Who is the CEO of Fauna Bio?
Ashley Zehnder is listed as CEO at Fauna Bio.
Where is Fauna Bio headquartered?
Fauna Bio is based in Berkeley, California, United States.
How many employees does Fauna Bio have?
Fauna Bio is in the 11-50 employee band.
How does Fauna Bio's funding compare to other Biotechnology startups?
Fauna Bio's latest round of $9.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Fauna Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Fauna Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.